PKCα suppresses 7,12-dimethylbenz[a]anthracene-induced skin tumor formation

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3097-3101

  Hara, Takeshi ^a   Matsumura, Shoji ^a   Hakuno, Fumihiko ^a   Takahashi, Shin Ichiro ^a   Chida, Kazuhiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

DMBA; Knockout mouse; PKC ; Skin carcinogenesis; Tumor progression

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYCLINE; PROTEIN KINASE C ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TUMOR GROWTH;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; MICE; MICE, KNOCKOUT; PROTEIN KINASE C-ALPHA; SKIN NEOPLASMS;

EID: 84865688957     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ohno S and Nishizuka Y: Protein kinase C isotypes and their specific functions: prologue. J Biochem 132: 509-511, 2002.
2. Mueller MM: Inflammation in epithelial skin tumours: Old stories and new ideas. Eur J Cancer 42: 735-744, 2006.
3. Nakashima S: Protein kinase C α (PKC α): regulation and biological function. J Biochem 132: 669-675, 2002.
4. Hara T, Saito Y, Hirai T, Nakamura K, Nakao K, Katsuki M and Chida K: Deficiency of protein kinase Cα in mice results in impairment of epidermal hyperplasia and enhancement of tumor formation in two-stage skin carcinogenesis. Cancer Res 65: 7356-7362, 2005.
5. Oster H and Leitges M: Protein kinase C α but not PKCζ suppresses intestinal tumor formation in ApcMin/+ mice. Cancer Res 66: 6955-6963, 2006.
6. Dean N, McKay R, Miraglia L, Howard R, Cooper S, Giddings J, Nicklin P, Meister L, Ziel R, Geiger T, Muller M and Fabbro D: Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-α expression. Cancer Res 56: 3499-3507, 1996.
7. Haughian JM, Reno EM, Thorne AM and Bradford AP: Protein kinase C alpha-dependent signaling mediates endometrial cancer cell growth and tumorigenesis. Int J Cancer 125: 2556-2564, 2009.
8. Tan M, Li P, Sun M, Yin G and Yu D: Up-regulation and activation of PKCα by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKCα and Src inhibitors. Oncogene 25: 3286-3295, 2006.
9. Cataisson C, Ohman R, Patel G, Pearson A, Tsien M, Jay S, Wright L, Hennings H and Yuspa SH: Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis. Cancer Res 69: 319-328, 2009.
10. Wang HQ and Smart RC: Overexpression of protein kinase C-α in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-α expression but not tumor promotion. J Cell Sci 112: 3497-3506, 1999.
11. Jansen AP, Dreckschmidt NE, Verwiebe EG, Wheeler DL, Oberley TD and Verma AK: Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase Cα, -δ and -ε transgenic mice. Int J Cancer 93: 635-643, 2001.
12. Aldaz CM, Conti CJ, Klein-Szanto AJ and Slaga TJ: Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy. Proc Natl Acad Sci USA 84: 2029-2032, 1987.
13. Klein-Szanto AJP: Pathology of human experimental skin tumors. In: Skin Tumors: Experimental and Clinical Aspects. Conti CJ, Slaga TJ, Klein-Szanto AJP (eds.). Raven Press, New York, pp. 19-53, 1989.
14. Scaglione-Sewell B, Abraham C, Bissonnette M, Skarosi SF, Hart J, Davidson NO, Wali RK, Davis BH, Sitrin M and Brasitus TA: Decreased PKC-α expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells. Cancer Res 58: 1074-1081, 1998.
15. Kim J, Thorne S H, Sun L, Huang B and Mochly-Rosen D: Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model. Oncogene 30: 323-333, 2011.
16. Gao J, Lauer FT, Dunaway S and Burchiel SW: Cytochrome P450 1B1 is required for 7,12-dimethylbenz(a)-anthracene (DMBA) induced spleen cell immunotoxicity. Toxicol Sci 86: 68-74, 2005.
17. DiGiovanni J: Multistage carcinogenesis in mouse skin. Pharmacol Ther 54: 63-128, 1992.
18. Paz-Ares L, Douillard JY, Koralewski P, Manegold C, Smit EF, Reyes JM, Chang GC, John WJ, Peterson PM, Obasaju CK, Lahn M and Gandara DR: Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 24: 1428-1434, 2006.
19. Marshall JL, Eisenberg SG, Johnson MD, Hanfelt J, Dorr FA, El-Ashry D, Oberst M, Fuxman Y, Holmlund J and Malik S: A phase II trial of ISIS 3521 in patients with metastatic colorectal cancer. Clin Colorectal Cancer 4: 268-274, 2004.